The federal government has scheduled a public meeting and issued a request for information as it works to develop a risk-based regulatory framework for health information technology.

The goal of the framework, which likely will include deeming certain mobile apps as medical devices and subject to Food and Drug Administration regulation, is to promote innovation, protect patient safety and avoid regulatory duplication, according to a notice being published May 30 and now available here. The notice is a joint publication from FDA, the Office of the National Coordinator for Health Information Technology and the Federal Communications Commission.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access